Financials in USD. Standardized financial statements.
A compact view of how Co-Diagnostics, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $622,489 | $3.92M | $6.81M | $34.22M | $97.89M | $74.55M | $214,974 | $39,911 | $7,662 | $0 |
| Revenue Growth? | -84.1% | -42.5% | -80.1% | -65.0% | +31.3% | +34579.9% | +438.6% | +420.9% | 0.0% | 0.0% |
| Cost of Revenue? | $222,377 | $999,124 | $4.18M | $5.48M | $11.57M | $16.59M | $112,431 | $9,391 | $302 | $37,491 |
| Gross Profit? | $400,112 | $2.92M | $2.63M | $28.74M | $86.31M | $57.96M | $102,543 | $30,520 | $7,360 | -$37,491 |
| Gross Margin? | +64.3% | +74.5% | +38.6% | +84.0% | +88.2% | +77.7% | +47.7% | +76.5% | +96.1% | 0.0% |
| Operating Expenses? | $31.68M | $43.00M | $45.33M | $55.72M | $40.25M | $16.27M | $6.00M | $6.15M | $4.57M | $1.65M |
| Operating Income? | -$31.28M | -$40.08M | -$42.71M | -$26.98M | $46.06M | $41.69M | -$5.89M | -$6.12M | -$4.56M | -$1.69M |
| EBITDA? | -$30.18M | -$38.70M | -$41.48M | -$10.31M | $46.40M | $41.83M | -$6.02M | -$6.09M | -$6.60M | -$1.65M |
| Income Before Tax | -$48.51M | -$37.58M | -$38.11M | -$18.85M | $45.64M | $42.57M | -$6.20M | -$6.27M | -$6.96M | -$1.93M |
| Income Tax Expense | -$1.62M | $57,368 | -$2.78M | -$4.61M | $8.98M | $90,536 | $0 | -$18,960 | $0 | $0 |
| Net Income? | -$46.90M | -$37.64M | -$35.33M | -$14.24M | $36.66M | $42.48M | -$6.20M | -$6.27M | -$6.96M | -$1.93M |
| EPS? | $-35.25 | $-37.20 | $-36.00 | $-13.57 | $38.10 | $1.59 | $-11.09 | $-15.00 | $-18.90 | $-5.10 |
| Diluted EPS? | $-35.25 | $-37.20 | $-36.00 | $-13.57 | $36.90 | $1.52 | $-11.09 | $-15.00 | $-18.90 | $-5.10 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality